Top Pharmaceuticals companies in United States by EPS (Diluted)

This ranking features the top 665 Pharmaceuticals companies in United States ranked by EPS (Diluted), averaging a EPS (Diluted) of USD -14.51, for January 15, 2025.

United States

Pharmaceuticals

#	Name	EPS (Diluted)	Reported Date	Stock Price	Change	Country
1	Inhibrx Biosciences, Inc. 1 INBX	USD 119.47	Sept. 30, 2024	USD 12.74	-6.60%	United States
2	Regeneron Pharmaceuticals, Inc. 2 REGN	USD 40.41	Sept. 30, 2024	USD 690.87	-3.63%	United States
3	Immuneering Corporation 3 IMRX	USD 38.83	Sept. 30, 2023	USD 1.95	-2.99%	United States
4	Tenet Healthcare Corporation 4 THC	USD 31.25	Sept. 30, 2024	USD 127.63	-1.27%	United States
5	United Therapeutics Corporation 5 UTHR	USD 22.77	Sept. 30, 2024	USD 364.70	0.50%	United States
6	McKesson Corporation 6 MCK	USD 19.29	Sept. 30, 2024	USD 593.73	1.48%	United States
7	Thermo Fisher Scientific Inc. 7 TMO	USD 15.94	Sept. 28, 2024	USD 556.99	0.27%	United States
8	UnitedHealth Group Incorporated 8 UNH	USD 15.35	Sept. 30, 2024	USD 543.74	0.48%	United States
9	Medpace Holdings, Inc. 9 MEDP	USD 11.42	Sept. 30, 2024	USD 330.91	-5.99%	United States
10	Agios Pharmaceuticals, Inc. 10 AGIO	USD 11.36	Sept. 30, 2024	USD 33.32	-2.86%	United States
11	Humana Inc. 11 HUM	USD 11.29	Sept. 30, 2024	USD 282.63	-1.65%	United States
12	Biogen Inc. 12 BIIB	USD 11.07	Sept. 30, 2024	USD 143.06	-4.74%	United States
13	Cigna Corporation 13 CI	USD 10.60	Sept. 30, 2024	USD 285.03	0.91%	United States
14	Waters Corporation 14 WAT	USD 10.49	Sept. 28, 2024	USD 404.93	1.26%	United States
15	IDEXX Laboratories, Inc. 15 IDXX	USD 10.37	Sept. 30, 2024	USD 418.63	-0.94%	United States
16	DaVita Inc. 16 DVA	USD 9.27	Sept. 30, 2024	USD 162.00	3.15%	United States
17	Eli Lilly and Company 17 LLY	USD 9.14	Sept. 30, 2024	USD 744.91	-6.59%	United States
18	Charles River Laboratories International, Inc. 18 CRL	USD 8.10	Sept. 28, 2024	USD 178.08	-6.34%	United States
19	Amgen Inc. 19 AMGN	USD 7.81	Sept. 30, 2024	USD 267.10	-1.14%	United States
20	IQVIA Holdings Inc. 20 IQV	USD 7.62	Sept. 30, 2024	USD 197.96	-3.26%	United States
21	ResMed Inc. 21 RMD	USD 7.55	Sept. 30, 2024	USD 228.83	-0.62%	United States
22	Cencora 22 COR	USD 7.51	Sept. 30, 2024	USD 240.05	1.68%	United States
23	Quest Diagnostics Incorporated 23 DGX	USD 7.45	Sept. 30, 2024	USD 152.98	-0.19%	United States
24	Edwards Lifesciences Corporation 24 EW	USD 6.93	Sept. 30, 2024	USD 71.04	-0.07%	United States
25	Quaker Chemical Corporation 25 KWR	USD 6.82	Sept. 30, 2024	USD 132.16	2.36%	United States
26	West Pharmaceutical Services, Inc. 26 WST	USD 6.74	Sept. 30, 2024	USD 328.96	-3.13%	United States
27	Kewaunee Scientific Corporation 27 KEQU	USD 6.31	Oct. 31, 2024	USD 55.91	1.29%	United States
28	Intuitive Surgical, Inc. 28 ISRG	USD 6.22	Sept. 30, 2024	USD 538.88	-0.16%	United States
29	Johnson & Johnson 29 JNJ	USD 6.05	Sept. 29, 2024	USD 144.75	0.19%	United States
30	Lantheus Holdings, Inc. 30 LNTH	USD 6.01	Sept. 30, 2024	USD 92.62	-2.15%	United States
31	Becton, Dickinson and Company 31 BDX	USD 5.94	Sept. 30, 2024	USD 235.80	-0.17%	United States
32	Insulet Corporation 32 PODD	USD 5.88	Sept. 30, 2024	USD 267.04	-0.35%	United States
33	Centene Corporation 33 CNC	USD 5.76	Sept. 30, 2024	USD 63.40	-0.47%	United States
34	Zoetis Inc. 34 ZTS	USD 5.32	Sept. 30, 2024	USD 164.41	-1.15%	United States
35	Zimmer Biomet Holdings, Inc. 35 ZBH	USD 5.26	Sept. 30, 2024	USD 104.71	-0.74%	United States
36	Danaher Corporation 36 DHR	USD 5.24	Sept. 27, 2024	USD 237.62	-0.94%	United States
37	Laboratory Corporation of America Holdings 37 LH	USD 5.17	Sept. 30, 2024	USD 234.50	0.17%	United States
38	Cardinal Health, Inc. 38 CAH	USD 5.15	Sept. 30, 2024	USD 124.03	2.62%	United States
39	Organon & Co. 39 OGN	USD 5.04	Sept. 30, 2024	USD 15.81	0.96%	United States
40	Teleflex Incorporated 40 TFX	USD 5.03	Sept. 29, 2024	USD 179.17	0.35%	United States
41	AptarGroup, Inc. 41 ATR	USD 4.98	Sept. 30, 2024	USD 154.61	0.47%	United States
42	Merck & Co., Inc. 42 MRK	USD 4.77	Sept. 30, 2024	USD 99.65	-1.32%	United States
43	Agilent Technologies, Inc. 43 A	USD 4.42	Oct. 31, 2024	USD 143.43	1.04%	United States
44	Utah Medical Products, Inc. 44 UTMD	USD 4.27	Sept. 30, 2024	USD 61.49	0.77%	United States
45	CONMED Corporation 45 CNMD	USD 4.21	Sept. 30, 2024	USD 67.79	-2.46%	United States
46	Prestige Consumer Healthcare Inc. 46 PBH	USD 4.11	Sept. 30, 2024	USD 75.78	1.54%	United States
47	CVS Health Corporation 47 CVS	USD 3.95	Sept. 30, 2024	USD 51.57	0.10%	United States
48	Hawkins, Inc. 48 HWKN	USD 3.91	Sept. 29, 2024	USD 111.93	0.99%	United States
49	Neurocrine Biosciences, Inc. 49 NBIX	USD 3.73	Sept. 30, 2024	USD 139.51	-2.46%	United States
50	Balchem Corporation 50 BCPC	USD 3.72	Sept. 30, 2024	USD 158.62	1.47%	United States

1 2 3 4 … 14

Frequently Asked Questions

Which Pharmaceuticals company in United States has the highest EPS (Diluted) ?

The Pharmaceuticals company in United States with the highest EPS (Diluted) is Inhibrx Biosciences, Inc. (NasdaqGS: INBX) at USD 119.47.
Which Pharmaceuticals company in United States has the lowest EPS (Diluted) ?

The Pharmaceuticals company in United States with the lowest EPS (Diluted) is Cingulate Inc. (NasdaqCM: CING) at USD -3,599.97.

What are the top 10 Pharmaceuticals companies in United States by EPS (Diluted) ?

The top 10 Pharmaceuticals companies in United States by EPS (Diluted) are Inhibrx Biosciences, Inc., Regeneron Pharmaceuticals, Inc., Immuneering Corporation, Tenet Healthcare Corporation, United Therapeutics Corporation, McKesson Corporation, Thermo Fisher Scientific Inc., UnitedHealth Group Incorporated, Medpace Holdings, Inc. and Agios Pharmaceuticals, Inc..
What are the bottom 10 Pharmaceuticals companies in United States by EPS (Diluted) ?

The bottom 10 Pharmaceuticals companies in United States by EPS (Diluted) are Cingulate Inc., Nutex Health, Inc., Annovis Bio, Inc., Inovio Pharmaceuticals, Inc., Allarity Therapeutics, Inc., Avalo Therapeutics, Inc., Nuwellis, Inc., Cartesian Therapeutics, Inc., NeueHealth, Inc. and Mesa Laboratories, Inc..